Ahmedabad, India: GIOSTAR India, a leading global institution in stem cell therapy and regenerative medicine, has announced a major expansion of its services at their three fully operational hospitals in three metro cities of the country i.e. Ahmedabad, Bangalore, and Chandigarh. GIOSTAR, international headquartered in the United States, is leading the way in the innovative field of medical treatments that is set to transform the healthcare industry globally including India, especially in the field of regenerative medicine.
Stem cell therapy has become an integral aspect of regenerative medical treatments in this modern era. It has the potential to manage and treat various chronic incurable diseases such as Diabetes (type 1 and type 2), Cancer, Sickle cell anemia, neural diseases, Osteoarthritis, etc. GIOSTAR India has already made remarkable strides in using Stem cell therapy to manage metabolic or degenerative diseases like diabetes and arthritis, offering hopes to millions affected by these indications.
The opening of a dedicated hospital and research center in Chandigarh marks a major milestone in the fight against various diseases including dreaded cancer in Northern India. This state-of-the-art facility is positioned to become a hub for advanced cancer research and treatment, harnessing the power of stem cells to provide new therapeutic options for patients. With stem cell therapy, there is immense potential to not only manage cancer but also reduce the need for organ donations, further broadening its scope and impact.
Dr Anand Srivastava, who has won a USA Congressional Recognition award for his work in Stem Cell Science, says that stem cell therapy is the future of regenerative medicine. GIOSTAR India's progress in stem cell research is creating new treatment options, particularly for chronic diseases like diabetes, arthritis, and cancer. The Chandigarh center will be a game-changer for patients in North India, bringing advanced medical solutions closer to home.
While the field of regenerative medicine continues to evolve, its applications are expanding at a rapid pace. GIOSTAR India's commitment to continue research and development in the field ensures that it remains at the forefront of this medical revolution, bringing innovative therapies to patients who need them the most.
For more information about GIOSTAR India and its initiatives in regenerative medicine, visit www.giostarindia.com or contact to:
Giostar Ahmedabad: +91-7043008890
Giostar Bangalore: +91-6366209990
Giostar Chandigarh: +91-9501768105